Option Care Health, Inc.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on February 24, 2026.
OPTION CARE HEALTH, INC.
/s/ Meenal Sethna
Meenal Sethna
Chief Financial Officer and Executive Vice President(Principal Financial Officer and Duly Authorized Officer)
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities on the dates indicated.
| Signature | Title(s) | Date |
|---|---|---|
| /s/ John C. RademacherJohn C. Rademacher | Chief Executive Officer, President and Director(Principal Executive Officer) | February 24, 2026 |
| /s/ Meenal SethnaMeenal Sethna | Chief Financial Officer and Executive Vice President(Principal Financial Officer) | February 24, 2026 |
| /s/ Nicole MaggioNicole Maggio | Senior Vice President, Corporate Controller(Principal Accounting Officer) | February 24, 2026 |
| /s/ Harry M. Jansen Kraemer, Jr.Harry M. Jansen Kraemer, Jr. | Non-Executive Chairman of the Board | February 24, 2026 |
| /s/ Elizabeth Q. BettenElizabeth Q. Betten | Director | February 24, 2026 |
| /s/ Elizabeth D. BierbowerElizabeth D. Bierbower | Director | February 24, 2026 |
| /s/ Barbara W. BodemBarbara W. Bodem | Director | February 24, 2026 |
| /s/ Eric K. BrandtEric K. Brandt | Director | February 24, 2026 |
| /s/ Natasha DeckmannNatasha Deckmann | Director | February 24, 2026 |
| /s/ David W. GoldingDavid W. Golding | Director | February 24, 2026 |
| /s/ R. Carter PateR. Carter Pate | Director | February 24, 2026 |
| /s/ Timothy P. SullivanTimothy P. Sullivan | Director | February 24, 2026 |
| /s/ Norman L. WrightNorman L. Wright | Director | February 24, 2026 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.